Single-centre experience shows significant differences in PET scans, suggesting tracer interchangeability for prostate cancer.
Consistent, predictable, and significant differences were observed in ¹⁸F-PSMA-1007 and [⁶⁸Ga]Ga-PSMA-11 PET scans of lesion, liver, volume surrogates, supporting tracer interchangeability for patients with suspected prostate cancer. Our results also support the recent commissioning of PSMA-based PET tracers in England.
No takes yet. Share an insight, caveat, or question.
Sanghera et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: